Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Detrimental Outcomes of Unmasking Cryptococcal Meningitis With Recent ART Initiation.

Rhein J, Hullsiek KH, Evans EE, Tugume L, Nuwagira E, Ssebambulidde K, Kiggundu R, Mpoza E, Musubire AK, Bangdiwala AS, Bahr NC, Williams DA, Abassi M, Muzoora C, Meya DB, Boulware DR; ASTRO-CM study team .

Open Forum Infect Dis. 2018 May 24;5(8):ofy122. doi: 10.1093/ofid/ofy122. eCollection 2018 Aug.

2.

Early versus delayed antiretroviral treatment in HIV-positive people with cryptococcal meningitis.

Eshun-Wilson I, Okwen MP, Richardson M, Bicanic T.

Cochrane Database Syst Rev. 2018 Jul 24;7:CD009012. doi: 10.1002/14651858.CD009012.pub3. Review.

3.

Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis.

Boulware DR, Meya DB, Muzoora C, Rolfes MA, Huppler Hullsiek K, Musubire A, Taseera K, Nabeta HW, Schutz C, Williams DA, Rajasingham R, Rhein J, Thienemann F, Lo MW, Nielsen K, Bergemann TL, Kambugu A, Manabe YC, Janoff EN, Bohjanen PR, Meintjes G; COAT Trial Team.

N Engl J Med. 2014 Jun 26;370(26):2487-98. doi: 10.1056/NEJMoa1312884.

4.

Cryptococcal Antigenemia in HIV therapy-experienced Ugandans with Virologic Failure.

Mpoza E, Rajasingham R, Tugume L, Rhein J, Nabaggala MS, Ssewanyana I, Nyegenye W, Kushemererwa GE, Mulema V, Kalamya J, Kiyaga C, Kabanda J, Ssali M, Boulware DR, Meya DB.

Clin Infect Dis. 2019 Nov 3. pii: ciz1069. doi: 10.1093/cid/ciz1069. [Epub ahead of print]

PMID:
31679007
5.

Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study.

Rhein J, Morawski BM, Hullsiek KH, Nabeta HW, Kiggundu R, Tugume L, Musubire A, Akampurira A, Smith KD, Alhadab A, Williams DA, Abassi M, Bahr NC, Velamakanni SS, Fisher J, Nielsen K, Meya DB, Boulware DR; ASTRO-CM Study Team.

Lancet Infect Dis. 2016 Jul;16(7):809-818. doi: 10.1016/S1473-3099(16)00074-8. Epub 2016 Mar 10.

6.

Comparison of cryptococcal antigenemia between antiretroviral naïve and antiretroviral experienced HIV positive patients at two hospitals in Ethiopia.

Beyene T, Woldeamanuel Y, Asrat D, Ayana G, Boulware DR.

PLoS One. 2013 Oct 4;8(10):e75585. doi: 10.1371/journal.pone.0075585. eCollection 2013.

7.

Ischemic stroke as a complication of cryptococcal meningitis and immune reconstitution inflammatory syndrome: a case report.

Ellis JP, Kalata N, Joekes EC, Kampondeni S, Benjamin LA, Harrison TS, Lalloo DG, Heyderman RS.

BMC Infect Dis. 2018 Oct 16;18(1):520. doi: 10.1186/s12879-018-3386-0.

8.

HIV combination therapy: partial immune restitution unmasking latent cryptococcal infection.

Woods ML 2nd, MacGinley R, Eisen DP, Allworth AM.

AIDS. 1998 Aug 20;12(12):1491-4.

PMID:
9727570
9.

Neurocognitive function in HIV-infected persons with asymptomatic cryptococcal antigenemia: a comparison of three prospective cohorts.

Montgomery MP, Nakasujja N, Morawski BM, Rajasingham R, Rhein J, Nalintya E, Williams DA, Huppler Hullsiek K, Kiragga A, Rolfes MA, Donahue Carlson R, Bahr NC, Birkenkamp KE, Manabe YC, Bohjanen PR, Kaplan JE, Kambugu A, Meya DB, Boulware DR; COAT and ORCAS Trial Teams.

BMC Neurol. 2017 Jun 12;17(1):110. doi: 10.1186/s12883-017-0878-2.

10.

Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis.

Bisson GP, Molefi M, Bellamy S, Thakur R, Steenhoff A, Tamuhla N, Rantleru T, Tsimako I, Gluckman S, Ravimohan S, Weissman D, Tebas P.

Clin Infect Dis. 2013 Apr;56(8):1165-73. doi: 10.1093/cid/cit019. Epub 2013 Jan 29. Erratum in: Clin Infect Dis. 2013 Oct;57(7):1067.

PMID:
23362285
11.

Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settings.

Meya DB, Manabe YC, Castelnuovo B, Cook BA, Elbireer AM, Kambugu A, Kamya MR, Bohjanen PR, Boulware DR.

Clin Infect Dis. 2010 Aug 15;51(4):448-55. doi: 10.1086/655143.

12.

Interleukin-17 mediated differences in the pathogenesis of HIV-1-associated tuberculous and cryptococcal meningitis.

Marais S, Meintjes G, Lesosky M, Wilkinson KA, Wilkinson RJ.

AIDS. 2016 Jan 28;30(3):395-404. doi: 10.1097/QAD.0000000000000904.

13.

Implementation and operational research: Integrated pre-antiretroviral therapy screening and treatment for tuberculosis and cryptococcal antigenemia.

Pac L, Horwitz MM, Namutebi AM, Auerbach BJ, Semeere A, Namulema T, Schwarz M, Bbosa R, Muruta A, Meya DB, Manabe YC.

J Acquir Immune Defic Syndr. 2015 Apr 15;68(5):e69-76. doi: 10.1097/QAI.0000000000000527.

14.

Management of cryptococcal meningitis in HIV-infected patients: Experience from western India.

Patel AK, Patel KK, Ranjan R, Shah S, Patel JK.

Indian J Sex Transm Dis AIDS. 2010 Jan;31(1):22-6. doi: 10.4103/0253-7184.68996.

15.

Early ART After Cryptococcal Meningitis Is Associated With Cerebrospinal Fluid Pleocytosis and Macrophage Activation in a Multisite Randomized Trial.

Scriven JE, Rhein J, Hullsiek KH, von Hohenberg M, Linder G, Rolfes MA, Williams DA, Taseera K, Meya DB, Meintjes G, Boulware DR; COAT Team.

J Infect Dis. 2015 Sep 1;212(5):769-78. doi: 10.1093/infdis/jiv067. Epub 2015 Feb 4.

16.

Immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis: a prospective study.

Bicanic T, Meintjes G, Rebe K, Williams A, Loyse A, Wood R, Hayes M, Jaffar S, Harrison T.

J Acquir Immune Defic Syndr. 2009 Jun 1;51(2):130-4. doi: 10.1097/QAI.0b013e3181a56f2e.

PMID:
19365271
17.

Optimal timing for antiretroviral therapy initiation in patients with HIV infection and concurrent cryptococcal meningitis.

Njei B, Kongnyuy EJ, Kumar S, Okwen MP, Sankar MJ, Mbuagbaw L.

Cochrane Database Syst Rev. 2013 Feb 28;(2):CD009012. doi: 10.1002/14651858.CD009012.pub2. Review. Update in: Cochrane Database Syst Rev. 2018 Jul 24;7:CD009012.

PMID:
23450595
18.

Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study.

Boulware DR, Meya DB, Bergemann TL, Wiesner DL, Rhein J, Musubire A, Lee SJ, Kambugu A, Janoff EN, Bohjanen PR.

PLoS Med. 2010 Dec 21;7(12):e1000384. doi: 10.1371/journal.pmed.1000384.

19.

Treatment for HIV-associated cryptococcal meningitis.

Tenforde MW, Shapiro AE, Rouse B, Jarvis JN, Li T, Eshun-Wilson I, Ford N.

Cochrane Database Syst Rev. 2018 Jul 25;7:CD005647. doi: 10.1002/14651858.CD005647.pub3. Review.

20.

Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa.

Jarvis JN, Lawn SD, Vogt M, Bangani N, Wood R, Harrison TS.

Clin Infect Dis. 2009 Apr 1;48(7):856-62. doi: 10.1086/597262.

Supplemental Content

Support Center